BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15047498)

  • 1. [Luminex technology for HLA typing by PCR-SSO and identification of HLA antibody specificities].
    Cesbron-Gautier A; Simon P; Achard L; Cury S; Follea G; Bignon JD
    Ann Biol Clin (Paris); 2004; 62(1):93-8. PubMed ID: 15047498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA typing using bead-based methods.
    Trajanoski D; Fidler SJ
    Methods Mol Biol; 2012; 882():47-65. PubMed ID: 22665228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical cytometry and progress in HLA antibody detection.
    Bray RA; Tarsitani C; Gebel HM; Lee JH
    Methods Cell Biol; 2011; 103():285-310. PubMed ID: 21722808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometry PRA using lymphocyte pools from random donors.
    Won DI; Jung HD; Jung OJ; Huh S; Suh JS
    Cytometry B Clin Cytom; 2007 Jul; 72(4):256-64. PubMed ID: 17205570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a new HLA-DRB real-time PCR typing method.
    Casamitjana N; Faner R; Santamaria A; Colobran R; Ribera A; Pujol-Borrell R; Juan M; Palou E
    Hum Immunol; 2005 Jan; 66(1):85-91. PubMed ID: 15620466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Methods for identification of HLA antigen polymorphisms].
    Novota P; Cerná M; Andĕl M
    Cas Lek Cesk; 2002 Mar; 141(6):171-5. PubMed ID: 11977834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of donor-specific antibodies using HLA-coated microspheres: another tool for kidney transplant risk stratification.
    Gibney EM; Cagle LR; Freed B; Warnell SE; Chan L; Wiseman AC
    Nephrol Dial Transplant; 2006 Sep; 21(9):2625-9. PubMed ID: 16644776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Luminex technology for anti-HLA antibody screening: evaluation of performance and of impact on laboratory routine.
    Colombo MB; Haworth SE; Poli F; Nocco A; Puglisi G; Innocente A; Serafini M; Messa P; Scalamogna M
    Cytometry B Clin Cytom; 2007 Nov; 72(6):465-71. PubMed ID: 17397064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-B27 typing: evaluation of an allele-specific PCR melting assay and two flow cytometric antigen assays.
    Seipp MT; Erali M; Wies RL; Wittwer C
    Cytometry B Clin Cytom; 2005 Jan; 63(1):10-5. PubMed ID: 15624199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Luminex-Based Methods in High-Resolution HLA Typing.
    Testi M; Andreani M
    Methods Mol Biol; 2015; 1310():231-45. PubMed ID: 26024639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA typing of HLA-B27 by polymerase chain reaction.
    Lucotte G; Burckel A
    Mol Cell Probes; 1997 Aug; 11(4):313-5. PubMed ID: 9281420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review article: Luminex technology for HLA antibody detection in organ transplantation.
    Tait BD; Hudson F; Cantwell L; Brewin G; Holdsworth R; Bennett G; Jose M
    Nephrology (Carlton); 2009 Apr; 14(2):247-54. PubMed ID: 19207861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of the Luminex single antigen panel for detecting flow cytometry cross-match positivity.
    Moreno C; Burgos L; Pérez-Robles C; Delgado JA; Mata JJ; Errasti P; Martín P; Merino J; Sánchez-Ibarrola A
    Hum Immunol; 2012 May; 73(5):517-21. PubMed ID: 22425736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular typing of HLA genes using whole genome amplified DNA.
    Creary LE; Girdlestone J; Zamora J; Brown J; Navarrete CV
    Transfusion; 2009 Jan; 49(1):57-63. PubMed ID: 18954395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of serological and molecular results for HLA-DR typing in 120 Thai subjects.
    Nathalang O; Kupatawintu P; O'Charoen R; Sinsiri S; Saelee S; Tatsumi N
    Southeast Asian J Trop Med Public Health; 1999 Jun; 30(2):311-3. PubMed ID: 10774701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenging the golden standard in defining donor-specific antibodies: does the solid phase assay meet the expectations?
    Zoet YM; Brand-Schaaf SH; Roelen DL; Mulder A; Claas FH; Doxiadis II
    Tissue Antigens; 2011 Mar; 77(3):225-8. PubMed ID: 21299527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HLA-DR typing using PCR-SSO with simultaneous hybridization of each dot blot membrane with a digoxigenin- and a biotin-marked probe].
    Chen DF; Endres W; Meyer SA; Stangel W
    Beitr Infusionsther Transfusionsmed; 1994; 32():261-5. PubMed ID: 9480104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of crossmatch outcome of highly sensitized patients by single and/or multiple antigen bead luminex assay.
    Vaidya S; Partlow D; Susskind B; Noor M; Barnes T; Gugliuzza K
    Transplantation; 2006 Dec; 82(11):1524-8. PubMed ID: 17164726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA typing by microbead arrays and PCR-SSP: apparent false-negative or -positive hybridization or amplification signals disclose new HLA-B and -DRB1 alleles.
    Rahal M; Kervaire B; Villard J; Tiercy JM
    Tissue Antigens; 2008 Mar; 71(3):238-41. PubMed ID: 18179646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.